XORTX Therapeutics Inc. XRTX
1.69
(0.03)
(1.74%)
as of 25 Sep
- Market cap
- $3.2M
- P/E
- 0.0×
Follow XRTX
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
1.62 | 2.11 | 0.86 | 3.59 |
Net Debt/EBITDA |
1.74 | 1.32 | 0.31 | 0.59 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.97 | 1.19 | 0.62 | 1.93 | |
Capex/Depreciation |
(0.19) | (0.84) | (0.15) | (7.80) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.07 | 0.07 | 0.09 | 0.41 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.65) | (0.77) | (0.36) | (2.11) | |
Cash per Share |
1.23 | 0.91 | 0.18 | 0.61 | |
Shareholders Equity per Share |
2.03 | 2.20 | 0.92 | 3.40 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.03 | 2.20 | 0.92 | 3.40 | |
Free Cash Flow |
(0.64) | (0.73) | (0.51) | (3.41) | |
Working Capital |
0.52 | 0.66 | (0.12) | 1.76 | |
Capital Expenditures |
(0.01) | (0.02) | 0.00 | (0.14) | |
Net Current Asset Value |
0.52 | 0.66 | (0.12) | 1.76 | |
| Other line items | |||||
Quick Ratio |
1.45 | 1.58 | 0.37 | 1.59 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.65) | (0.74) | (0.36) | (2.02) | |
Capex per Share |
(0.01) | (0.03) | 0.00 | (0.09) | |
Average Receivables |
0.02 | 0.05 | 0.04 | 0.05 | |
Average Payables |
0.50 | 0.35 | 0.63 | 0.57 | |
Average Assets |
3.33 | 3.39 | 2.82 | 4.46 | |
Average Common Equity |
2.05 | 2.71 | 2.01 | 3.77 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates